BSE Live
Mar 30, 16:01Prev. Close
1795.65
Open Price
1795.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Mar 30, 16:05Prev. Close
1793.60
Open Price
1786.80
Bid Price (Qty.)
1757.20 (11671)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Sun Pharmaceutical Industries (in Rs. Cr.) | Mar 05 | Mar 04 | |
| Per Share Ratios | |||
| Basic EPS (Rs.) | 16.83 | 26.56 | |
| Diluted EPS (Rs.) | 16.83 | 26.56 | |
| Cash EPS (Rs.) | 18.74 | 29.10 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 59.51 | 91.00 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 59.51 | 91.00 | |
| Dividend / Share(Rs.) | 3.75 | 3.25 | |
| Revenue from Operations/Share (Rs.) | 54.29 | 90.99 | |
| PBDIT/Share (Rs.) | 18.89 | 34.20 | |
| PBIT/Share (Rs.) | 17.12 | 31.66 | |
| PBT/Share (Rs.) | 17.12 | 31.66 | |
| Net Profit/Share (Rs.) | 16.83 | 26.56 | |
| Profitability Ratios | |||
| PBDIT Margin (%) | 34.79 | 37.58 | |
| PBIT Margin (%) | 31.53 | 34.79 | |
| PBT Margin (%) | 31.53 | 34.79 | |
| Net Profit Margin (%) | 31.00 | 29.19 | |
| Return on Networth / Equity (%) | 28.28 | 29.19 | |
| Return on Capital Employed (%) | 10.71 | 25.88 | |
| Return on Assets (%) | 9.67 | 17.15 | |
| Total Debt/Equity (X) | 1.64 | 0.37 | |
| Asset Turnover Ratio (%) | 0.43 | 0.00 | |
| Liquidity Ratios | |||
| Current Ratio (X) | 6.60 | 1.59 | |
| Quick Ratio (X) | 5.89 | 1.06 | |
| Inventory Turnover Ratio (X) | 1.43 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 22.27 | 24.46 | |
| Dividend Payout Ratio (CP) (%) | 20.01 | 22.33 | |
| Earnings Retention Ratio (%) | 77.73 | 75.54 | |
| Cash Earnings Retention Ratio (%) | 79.99 | 77.67 | |
| Valuation Ratios | |||
| Enterprise Value (Cr.) | 9,671.43 | 6,280.42 | |
| EV/Net Operating Revenue (X) | 9.60 | 7.44 | |
| EV/EBITDA (X) | 27.60 | 19.80 | |
| MarketCap/Net Operating Revenue (X) | 8.68 | 7.14 | |
| Retention Ratios (%) | 77.72 | 75.53 | |
| Price/BV (X) | 7.92 | 7.14 | |
| Price/Net Operating Revenue | 8.68 | 7.14 | |
| Earnings Yield | 0.04 | 0.04 |
17.03.2026
09.03.2026
09.03.2026
04.02.2026
Buy Sun Pharmaceutical Industries; target of Rs 1900: Prabhudas Lilladher
03.02.2026
Sun Pharma Consolidated December 2025 Net Sales at Rs 15,520.54 crore, up 13.49% Y-o-Y
03.02.2026
Sun Pharma Standalone December 2025 Net Sales at Rs 5,687.77 crore, down 8.14% Y-o-Y
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
31.03.2026
30.03.2026
Wockhardt novel antibiotic Zaynich gets thumbs-up from CDSCO expert panel
30.03.2026
29.03.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth